Observational Recruiting
NCT06480955 on ClinicalTrials.gov
BOne Metastases REgistry for Patients Undergoing cryoAbLation With curatIve purpoSe
- Sponsor: Cardiovascular and Interventional Radiological Society of Europe
- Collaborators: Boston Scientific Corporation
- Enrollment: 50 (Estimated)
- Study start: 2025-04-01 (Actual)
- Primary completion: 2027-04-01 (Estimated)
- Study completion: 2028-04-01 (Estimated)
- Allocation: N/a
- InterventionModel: N/a
- Masking: None
- PrimaryPurpose: Other
Brief Summary
BOREALIS is a multicentre, prospective, observational cohort study designed to investigate the effectiveness, feasibility, safety and impact on pain and quality of life of curative-intent cryoablation for the treatment of bone metastases in patients with oligometastatic or bone oligo-progressive disease.
Conditions
- Bone Metastases
Intervention / Treatment
- Device: Cryoablation system
Primary Outcome Measures
-
Local progression-free survival rate
(12 months)
On a per lesion basis, proportion of target lesions free from local tumour progression using the Kaplan Meier estimate
Countries
France, Spain, Switzerland
Locations and Investigators
-
Institute Bergonié, Bordeaux, France (Recruiting)
- Xavier Buy, Dr (Principal Investigator)
-
CHRU de Strasbourg, Strasbourg, France (Recruiting)
- Roberto Luigi Cazzato, Dr (Principal Investigator)
-
Institut Gustave Roussy, Villejuif, France (Recruiting)
- Frederic Deschamps, Dr (Principal Investigator)
-
Hospital Universitario y Politécnico La Fe, Valencia, Spain (Recruiting)
- Fernando Gómez Muñoz, Dr (Principal Investigator)
-
CHUV-Lausanne University Hospital, Lausanne, Switzerland (Recruiting)
- Georgia Tsoumakidou, Dr (Principal Investigator)
Study Officials
- Roberto L Cazzato, Dr (Study Chair) — Strasbourg University Hospitals, Strasbourg, France